Holland Capital exits Inno4Life
Holland Capital has sold pharmaceutical packaging business Inno4Life to trade buyer Dec Group.
Dec made the acquisition to realise synergies between the two groups, as well as to expand the product portfolios of both companies.
Inno4Life will continue to operate under its name and trade under its brand for all its business activities.
Previous funding
Holland Capital provided growth capital and took a stake in Inno4Life in July 2017. At the time of investing, the GP was deploying from Holland Venture Entrepreneurs Fund III, which closed on €55m in December 2016.
Company
Based in Breda and founded in 2010, Inno4Life is a manufacturer of filling and packaging machines for the pharmaceutical industry.
People
Holland Capital – Jan-Frens van Giessel (healthcare partner).
Inno4Life – Johan Klootwijk (co-founder, managing director).
Advisers
Vendor – VINC Advisory (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









